早期的驱动者,晚期的旁观者:在人类AML中揭示了DNMT3A R882突变的特定阶段作用
Yubin Zhou1,2, Yun Huang1,2
1Institute of Biosciences and Technology, Texas A&M University, Houston, Texas.
Cancer discovery
|March 2, 2026
概括
DNA甲基转移酶3A (DNMT3A) R882突变对于早期白血病的发展至关重要,维持自我更新和炎症. 然而,一旦急性髓性白血病确立,这些突变变得不那么重要,这表明早期治疗干预.
科学领域:
- 血液学 血液学 血液学
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- DNA甲基转移酶3A (DNMT3A) 的突变在急性髓性白血病 (AML) 中很常见.
- 在DNMT3A中经常观察到阿金氨酸882 (R882) 突变,并且与预后不佳有关.
- 在白血病发生的不同阶段DNMT3A R882突变的确切作用仍然不完全理解.
研究的目的:
- 在人类急性髓性白血病中研究DNMT3A R882突变的特定阶段功能.
- 确定DNMT3A R882突变对于维持白血病干细胞特性是否有必要.
- 评估针对DNMT3A突变克隆的治疗窗口.
主要方法:
- 在人类AML样本中利用了基因基因特异性的CRISPR/Cas9校正.
- 剖析了DNMT3A R882突变在白血病前和确定的白血病阶段的功能影响.
- 对细胞自我更新,炎症程序和白血病干细胞频率的评估影响.
主要成果:
- DNMT3A R882突变对于维持白血病前细胞的自我更新和炎症程序至关重要.
- 一旦疾病确立,这些突变在很大程度上成为白血病维持的必需品.
- 即使在已确定的白血病中,DNMT3A R882突变也继续影响白血病干细胞频率.
结论:
- DNMT3A R882突变在AML的发展中起着关键的,特定阶段的作用,主要是在白血病前阶段.
- 针对DNMT3A突变克隆早期的白血病发生可能是一个可行的治疗策略.
- 这些发现为重新考虑DNMT3A突变AML治疗干预的时间提供了临床前的理由.
相关概念视频
02:23Abnormal Proliferation
5.3K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
02:36DNA Damage can Stall the Cell Cycle
10.3K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
10.3K
02:36DNA Damage Can Stall the Cell Cycle
3.3K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
3.3K
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
56
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
56
01:20Mismatch Repair
6.8K
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
6.8K
01:36Mismatch Repair
44.1K
Overview
44.1K